NasdaqCM - Delayed Quote USD
BioLineRx Ltd. (BLRX)
3.4400
+0.0400
+(1.18%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-43,873
-43,873
-22,608
-26,240
-23,573
Investing Cash Flow
29,374
29,374
1,444
4,006
-38,224
Financing Cash Flow
20,658
20,658
15,056
20,438
57,749
End Cash Position
10,436
10,436
4,255
10,587
12,990
Interest Paid Supplemental Data
10,387
10,387
1,111
593
682
Capital Expenditure
-54
-54
-297
-316
-97
Issuance of Capital Stock
16,357
16,357
14,089
14,359
50,407
Issuance of Debt
19,223
19,223
--
9,126
--
Repayment of Debt
-14,944
-14,944
-1,988
-3,052
-3,572
Free Cash Flow
-43,927
-43,927
-22,905
-26,556
-23,670
12/31/2021 - 7/27/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CANF Can-Fite BioPharma Ltd.
1.1250
+8.17%
PLX Protalix BioTherapeutics, Inc.
3.0000
0.00%
EVGN Evogene Ltd.
1.1800
+2.61%
XTLB XTL Biopharmaceuticals Ltd.
1.5000
-1.96%
ALDX Aldeyra Therapeutics, Inc.
2.8100
+3.69%
VTVT vTv Therapeutics Inc.
22.46
+5.55%
CLRB Cellectar Biosciences, Inc.
0.2707
+2.46%
CGEN Compugen Ltd.
1.4800
-2.63%
BTAI BioXcel Therapeutics, Inc.
1.7800
+0.28%
TOVX Theriva Biologics, Inc.
1.3800
-1.43%